CIK 0000879407
- Large accelerated filer
ARROWHEAD PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- ARWR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 460408024
- Phone
- +1 626-696-4702
- Business address
- 177 E COLORADO BLVD, SUITE 700, PASADENA, CA, 91105
- Former names
- ARROWHEAD RESEARCH CORP, INTERACTIVE GROUP INC, INTERACTIVE INC
- 4 Open-market sale Director sold 185,000 shares at an average $29.41 ($5,440,000)
- 4 Open-market sale Director sold 17,756 shares at $27.61 ($490,243)
- 4 Option exercise Chief Financial Officer acquired 35,000 shares (option exercise)
- 4 Open-market sale General Counsel sold 30,000 shares at $24.88 ($746,400)
- 4 Option exercise Chief Executive Officer acquired 49,448 shares (option exercise)
- 4 Open-market sale Chief Financial Officer sold 27,071 shares at $22.00 ($595,562)
- 4 Open-market sale Chief Executive Officer sold 50,000 shares at $19.30 ($965,000)
- 4 Open-market sale Chief Operating Officer sold 42,500 shares at $19.99 ($849,575)
- 4 Open-market sale Chief Operating Officer sold 42,500 shares at $18.98 ($806,650)
- 4 Open-market sale Director sold 68,000 shares at an average $19.20 ($1,305,400)
- 4 Open-market sale Chief Financial Officer sold 8,000 shares at $18.00 ($144,000)
- 4 Open-market sale Chief Operating Officer sold 68,750 shares at an average $17.86 ($1,227,988)
- 4 Open-market sale Chief Operating Officer sold 242,834 shares at an average $16.04 ($3,894,247)
- 4 Open-market sale Chief Operating Officer sold 22,500 shares at $14.48 ($325,800)
- 4 Open-market sale Chief Operating Officer sold 28,500 shares at $13.85 ($394,725)
- 4 Open-market sale Chief Operating Officer sold 169,500 shares at an average $13.54 ($2,295,805)
- 4 Open-market sale Director sold 3,000 shares at $13.58 ($40,740)
- 4 Open-market sale General Counsel sold 72,000 shares at $14.43 ($1,038,960)
- 4 Open-market sale Chief Financial Officer sold 81,875 shares at $14.55 ($1,191,281)
- 4 Open-market sale Snr. VP, Chem and Non-Clin Dev sold 40,500 shares at $14.34 ($580,770)
Page 12 of 25 · 497 filings